NXTC stock Statistics — NextCure, Inc. filings, insiders & smart money

Price chart (1D to 10Y)

Licensed market data — shown to members, not published to the open web.

Beta: Sign in
Shares outstandingAs of 2026-07-31 · filed common shares: 4.57M
Shares float: Sign in
Float %: Sign in
Insider ownership: —
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 1.01%
Short ratioDays to cover, as published by FINRA: 1.00
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 29.30%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 27.40%
Avg volume (10D)

Source: SEC filings. Information and analytics, not investment advice.

Rev growth (fwd)

Avg volume (3 months)

Gross margin: —
Operating margin: —
Net margin: —
EBITDA margin: —
Return on equityNet income (TTM to Jun 26) ÷ average shareholders equity: -204.56%
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: -121.60%

Cash & equivalentsas of Jun 26: $15.26M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $4.66M
Debt / equityas of Jun 26: 38.41%
Current ratioas of Jun 26: 3.47
Quick ratio: —
Operating cash flowTTM to Jun 26: -$36.98M
Free cash flowUnadjusted FCF = CFO − capex · TTM to Jun 26: -$36.98M
TTM revenue / diluted share: —